182 related articles for article (PubMed ID: 9846884)
1. Advanced glycation endproducts and cigarette smoking.
Nicholl ID; Bucala R
Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1025-33. PubMed ID: 9846884
[TBL] [Abstract][Full Text] [Related]
2. Increased levels of advanced glycation endproducts in the lenses and blood vessels of cigarette smokers.
Nicholl ID; Stitt AW; Moore JE; Ritchie AJ; Archer DB; Bucala R
Mol Med; 1998 Sep; 4(9):594-601. PubMed ID: 9848076
[TBL] [Abstract][Full Text] [Related]
3. Possible involvement of tobacco-derived advanced glycation end products (AGEs) in an increased risk for developing cancers and cardiovascular disease in former smokers.
Yamagishi S; Matsui T; Nakamura K
Med Hypotheses; 2008 Aug; 71(2):259-61. PubMed ID: 18448262
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potentials of unicellular green alga Chlorella in advanced glycation end product (AGE)-related disorders.
Yamagishi S; Nakamura K; Inoue H
Med Hypotheses; 2005; 65(5):953-5. PubMed ID: 15996828
[TBL] [Abstract][Full Text] [Related]
5. Protein crosslinking by the Maillard reaction: dicarbonyl-derived imidazolium crosslinks in aging and diabetes.
Chellan P; Nagaraj RH
Arch Biochem Biophys; 1999 Aug; 368(1):98-104. PubMed ID: 10415116
[TBL] [Abstract][Full Text] [Related]
6. The Maillard reaction and its consequences for a living body.
Sztanke K; Pasternak K
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):159-62. PubMed ID: 15323185
[TBL] [Abstract][Full Text] [Related]
7. Protein glycation: creation of catalytic sites for free radical generation.
Yim MB; Yim HS; Lee C; Kang SO; Chock PB
Ann N Y Acad Sci; 2001 Apr; 928():48-53. PubMed ID: 11795527
[TBL] [Abstract][Full Text] [Related]
8. Protein carbonylation and glycation in human lenses.
Balog Z; Klepac R; Sikić J; Jukić-Lesina T
Coll Antropol; 2001; 25 Suppl():145-8. PubMed ID: 11817006
[TBL] [Abstract][Full Text] [Related]
9. Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications.
Friedman EA
Diabetes Care; 1999 Mar; 22 Suppl 2():B65-71. PubMed ID: 10097902
[TBL] [Abstract][Full Text] [Related]
10. Pathobiology of the heart in experimental diabetes: immunolocalization of lipoproteins, immunoglobulin G, and advanced glycation endproducts proteins in diabetic and/or hyperlipidemic hamster.
Sima A; Popov D; Starodub O; Stancu C; Cristea C; Stern D; Simionescu M
Lab Invest; 1997 Jul; 77(1):3-18. PubMed ID: 9251674
[TBL] [Abstract][Full Text] [Related]
11. A novel pleiotropic effect of atorvastatin on advanced glycation end product (AGE)-related disorders.
Yamagishi S; Nakamura K; Matsui T; Inoue H
Med Hypotheses; 2007; 69(2):338-40. PubMed ID: 17329034
[TBL] [Abstract][Full Text] [Related]
12. The contribution of glycation to cataract formation in diabetes.
Stevens A
J Am Optom Assoc; 1998 Aug; 69(8):519-30. PubMed ID: 9747048
[TBL] [Abstract][Full Text] [Related]
13. Oral administration of AST-120 (Kremezin) is a promising therapeutic strategy for advanced glycation end product (AGE)-related disorders.
Yamagishi S; Nakamura K; Matsui T; Inoue H; Takeuchi M
Med Hypotheses; 2007; 69(3):666-8. PubMed ID: 17331665
[TBL] [Abstract][Full Text] [Related]
14. An agent cleaving glucose-derived protein crosslinks in vitro and in vivo.
Vasan S; Zhang X; Zhang X; Kapurniotu A; Bernhagen J; Teichberg S; Basgen J; Wagle D; Shih D; Terlecky I; Bucala R; Cerami A; Egan J; Ulrich P
Nature; 1996 Jul; 382(6588):275-8. PubMed ID: 8717046
[TBL] [Abstract][Full Text] [Related]
15. Potential therapeutic implication of nifedipine, a dihydropyridine-based calcium antagonist, in advanced glycation end product (AGE)-related disorders.
Yamagishi S; Nakamura K; Takeuchi M
Med Hypotheses; 2005; 65(2):392-4. PubMed ID: 15922119
[TBL] [Abstract][Full Text] [Related]
16. Naturally occurring inhibitors against the formation of advanced glycation end-products.
Peng X; Ma J; Chen F; Wang M
Food Funct; 2011 Jun; 2(6):289-301. PubMed ID: 21779567
[TBL] [Abstract][Full Text] [Related]
17. The maillard reaction in eye diseases.
Stitt AW
Ann N Y Acad Sci; 2005 Jun; 1043():582-97. PubMed ID: 16037281
[TBL] [Abstract][Full Text] [Related]
18. Chemical modification of proteins by methylglyoxal.
Degenhardt TP; Thorpe SR; Baynes JW
Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1139-45. PubMed ID: 9846896
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end products serve as ligands for lectin-like oxidized low-density lipoprotein receptor-1(LOX-1): biochemical and binding characterizations assay.
Chen X; Zhang T; Du G
Cell Biochem Funct; 2008 Oct; 26(7):760-70. PubMed ID: 18636435
[TBL] [Abstract][Full Text] [Related]
20. The effectiveness of putative anti-cataract agents in the prevention of protein glycation.
Stevens A
J Am Optom Assoc; 1995 Dec; 66(12):744-9. PubMed ID: 8557952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
